Finally, future studies may harness the power of new technologies like clustered regularly interspaced short palindromic repeats (CRISPR) genome editing in combination with human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes to decipher mechanisms by which genetic variants in JPH2 cause cardiac disease (213, 214). This evidence concerns the gene JPH2 and heart disorder.